Methods and compositions for amplification of RNA sequences

• US 8,071,311 B2
• Filed: 11/10/2009
• Issued: 12/06/2011
• Est. Priority Date: 03/09/2001
• Status: Expired due to Term

• Current Assignee: NuGEN Technologies, Inc. (Tecan Group AG)
• Original Assignee: NuGEN Technologies, Inc. (Tecan Group AG)
• Inventors: Kurn, Nurith
• Primary Examiner(s): Horlick, Kenneth R.
• Application Number:
  US12/615,958
• Publication Number:
  US 20100167354A1
• Time in Patent Office: 756 Days
• Field of Search: 435/6, 435/91.2, 435/6.12
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 2531/119 Strand displacement amplification [SDA]

Abstract

The invention provides methods for isothermal amplification of RNA. The methods are particularly suitable for amplifying a plurality of RNA species in a sample. The methods employ a composite primer, a second primer and strand displacement to generate multiple copies of DNA products comprising sequences complementary to an RNA sequence of interest. In another aspect, the methods employ a single primer (which is a composite primer) and strand displacement to generate multiple copies of DNA products comprising sequences complementary to an RNA sequence of interest. In some embodiments, a transcription step is included to generate multiple copies of sense RNA of an RNA sequence of interest. The methods are useful for preparation of nucleic acid libraries and substrates for analysis of gene expression of cells in biological samples. The invention also provides compositions and kits for practicing the amplification methods, as well as methods which use the amplification products.

Claims

1. A method for isothermally amplifying a target nucleic acid comprising

a) hybridizing a first RNA-DNA composite primer to the target nucleic acid;

b) extending said first RNA-DNA composite primer using a polymerase;

c) using RNase H, degrading a 5′

portion of said first RNA-DNA composite primer to leave a first product comprising a single-stranded 3′

overhang, wherein said 5′

portion forms a hybridized portion of a nucleic acid duplex prior to said degrading;

d) hybridizing a second RNA-DNA composite primer to the single-stranded 3′

overhang of the first product, wherein the second RNA-DNA composite primer comprises the same sequence as a 3′

portion of the first RNA-DNA composite primer that is not degraded in step (c);

e) displacing the extended first RNA-DNA composite primer by extending said second primer using a polymerase, such that said extended first primer is released from said target nucleic acid;

f) hybridizing a third RNA-DNA composite primer with said extended first RNA-DNA composite primer; and

g) repeating steps (b)-(e), wherein said first RNA-DNA composite primer is replaced by said third RNA-DNA composite primer to produce a second product, said RNA-DNA composite second RNA-DNA composite primer is replaced by a fourth RNA-DNA composite primer to displace an extended third RNA-DNA composite primer, and said fourth RNA-DNA composite primer comprises the same sequence as a 3′

portion of said third RNA-DNA composite primer that is not degraded in step (c);

whereby said target nucleic acid is amplified to produce amplified products.

2. The method of claim 1 wherein the target nucleic acid comprises RNA and said target nucleic acid is selected from the group consisting of total RNA, tRNA, mRNA, rRNA, mitochondrial RNA, chloroplast RNA, DNA-RNA hybrids, viral RNA, cell free RNA, and mixtures thereof.

3. The method of claim 1 wherein the amplified products are further immobilized on a solid substrate.

4. The method of claim 3 wherein each amplified product further comprises a moiety that is capable of attachment to a solid substrate.

5. The method of claim 4 wherein each amplified product further comprises a modified base or a nucleotide analog that comprises a moiety that is capable of attachment to a solid substrate.

6. The method of claim 1 wherein each of said first RNA-DNA composite primer, said second RNA-DNA composite primer, said third RNA-DNA composite primer, and said fourth RNA-DNA composite primer is a composite primer comprising a 5′

RNA portion and a 3′

DNA portion wherein the 5′

RNA portion comprises a defined sequence and the 3′

DNA portion comprises a random sequence.

7. The method of claim 1 wherein the amplification products are further labeled.

8. The method of claim 7 wherein the label is selected from the group consisting of fluorescent dyes, radioisotopes, enzymes, steroids, colorimetric labels, ligands, and anti-ligands.

9. The method of claim 1, wherein said first primer and said second primer have the same nucleotide sequence.

10. The method of claim 1, wherein the 5′

portion of said first primer and said third primer that is degraded in step (c) is an RNA portion of an RNA/DNA heteroduplex.

16. The method of claim 1, wherein said first primer and said second primer have the same nucleotide sequence.

11. A method for isothermally amplifying a target nucleic acid comprising

(a) hybridizing a first RNA-DNA composite primer to the target nucleic acid;

(b) extending said first RNA-DNA composite primer using a polymerase to produce a first primer extension product;

(c) hybridizing a second RNA-DNA composite primer to said first primer extension product;

(d) extending said second RNA-DNA composite primer using a polymerase to produce a first complex comprising a second primer extension product that is hybridized to said first primer extension product;

(e) using RNase H, degrading a 5′

portion of said first RNA-DNA composite primer in said first complex to produce a single-stranded 3′

overhang;

(f) hybridizing a third RNA-DNA composite primer to said single-stranded 3′

overhang produced in step (e), wherein said third RNA-DNA composite primer comprises the same sequence as a 3′

portion of the first RNA-DNA composite primer that is not degraded in step (e);

(g) displacing the first primer extension product by extending said third RNA-DNA composite primer using a polymerase to produce a second complex comprising a third primer extension product that is hybridized to said second primer extension product;

(h) using RNase H, degrading a 5′

portion of said second RNA-DNA composite primer in said second complex to produce a single-stranded 3′

overhang;

(i) hybridizing a fourth RNA-DNA composite primer to said single-stranded 3′

overhang produced in step (h), wherein said fourth RNA-DNA composite primer comprises the same sequence as a 3′

portion of the second RNA-DNA composite primer that is not degraded in step (h);

(j) displacing the second primer extension product by extending said fourth RNA-DNA composite primer using a polymerase to produce a third complex comprising a fourth primer extension product that is hybridized to said third primer extension product; and

,

(k) repeating steps (e) through (g) and steps (h) through (j) to amplify said target nucleic acid.

12. The method of claim 11, wherein the target nucleic acid comprises RNA.

13. The method of claim 11, wherein each of said first RNA-DNA composite primer, said second RNA-DNA composite primer, said third RNA-DNA composite primer, and said fourth RNA-DNA composite primer is a composite primer comprising a 5′

RNA portion and a 3′

DNA portion.

14. The method of claim 13, wherein said 5′

RNA portion comprises a defined sequence and the 3′

DNA portion comprises a random sequence.

15. The method of claim 13, wherein said 5′

RNA portion is degraded when hybridized to DNA as part of an RNA/DNA heteroduplex.